102 related articles for article (PubMed ID: 8286361)
1. Solution structure of RP 71955, a new 21 amino acid tricyclic peptide active against HIV-1 virus.
Fréchet D; Guitton JD; Herman F; Faucher D; Helynck G; Monegier du Sorbier B; Ridoux JP; James-Surcouf E; Vuilhorgne M
Biochemistry; 1994 Jan; 33(1):42-50. PubMed ID: 8286361
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of the solution structures of tachyplesin I and a novel anti-HIV synthetic peptide, T22 ([Tyr5,12, Lys7]-polyphemusin II), determined by nuclear magnetic resonance.
Tamamura H; Kuroda M; Masuda M; Otaka A; Funakoshi S; Nakashima H; Yamamoto N; Waki M; Matsumoto A; Lancelin JM
Biochim Biophys Acta; 1993 May; 1163(2):209-16. PubMed ID: 8490053
[TBL] [Abstract][Full Text] [Related]
3. Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection.
Wild CT; Shugars DC; Greenwell TK; McDanal CB; Matthews TJ
Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9770-4. PubMed ID: 7937889
[TBL] [Abstract][Full Text] [Related]
4. C-Terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread.
Medinas RJ; Lambert DM; Tompkins WA
J Virol; 2002 Sep; 76(18):9079-86. PubMed ID: 12186891
[TBL] [Abstract][Full Text] [Related]
5. NMR spectra and restrained molecular dynamics of the mushroom toxin viroisin.
Bhaskaran R; Yu C
Int J Pept Protein Res; 1994 Apr; 43(4):393-401. PubMed ID: 8045686
[TBL] [Abstract][Full Text] [Related]
6. Cycloviolins A-D, anti-HIV macrocyclic peptides from Leonia cymosa.
Hallock YF; Sowder RC; Pannell LK; Hughes CB; Johnson DG; Gulakowski R; Cardellina JH; Boyd MR
J Org Chem; 2000 Jan; 65(1):124-8. PubMed ID: 10813905
[TBL] [Abstract][Full Text] [Related]
7. Aqueous solution structure of a hybrid lentiviral Tat peptide and a model of its interaction with HIV-1 TAR RNA.
Mujeeb A; Parslow TG; Yuan YC; James TL
J Biomol Struct Dyn; 1996 Feb; 13(4):649-60. PubMed ID: 8906885
[TBL] [Abstract][Full Text] [Related]
8. The amino-terminal peptide of HIV-1 gp41 interacts with human serum albumin.
Gordon LM; Curtain CC; McCloyn V; Kirkpatrick A; Mobley PW; Waring AJ
AIDS Res Hum Retroviruses; 1993 Nov; 9(11):1145-56. PubMed ID: 8312056
[TBL] [Abstract][Full Text] [Related]
9. The solution structure of motilin from NMR distance constraints, distance geometry, molecular dynamics, and an iterative full relaxation matrix refinement.
Edmondson S; Khan N; Shriver J; Zdunek J; Gräslund A
Biochemistry; 1991 Nov; 30(47):11271-9. PubMed ID: 1958665
[TBL] [Abstract][Full Text] [Related]
10. Conformation of a cyclic opioid peptide analog by NMR and molecular dynamics simulation.
Chuang LC; Chen ST; Ya C
Biochim Biophys Acta; 1993 Nov; 1158(3):209-16. PubMed ID: 8251519
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional structure of the human immunodeficiency virus type 1 matrix protein.
Massiah MA; Starich MR; Paschall C; Summers MF; Christensen AM; Sundquist WI
J Mol Biol; 1994 Nov; 244(2):198-223. PubMed ID: 7966331
[TBL] [Abstract][Full Text] [Related]
12. Delineation of an active fragment and poly(L-proline) II conformation for candidacidal activity of bactenecin 5.
Raj PA; Marcus E; Edgerton M
Biochemistry; 1996 Apr; 35(14):4314-25. PubMed ID: 8605180
[TBL] [Abstract][Full Text] [Related]
13. Solution structure by NMR of circulin A: a macrocyclic knotted peptide having anti-HIV activity.
Daly NL; Koltay A; Gustafson KR; Boyd MR; Casas-Finet JR; Craik DJ
J Mol Biol; 1999 Jan; 285(1):333-45. PubMed ID: 9878410
[TBL] [Abstract][Full Text] [Related]
14. Effect of amino acid replacements, additions and deletions on the antiviral activity of a peptide derived from the HIV-1 GP41 sequence.
Jiang S; Lin K
Pept Res; 1995; 8(6):345-8. PubMed ID: 8838418
[TBL] [Abstract][Full Text] [Related]
15. [Synthesis of an ethylamide of the cyclic undecapeptide sequence 593-603 of transmembrane glycoprotein gp41 of the human immunodeficiency virus type 2].
Sidorova MV; Kudriavtseva EV; Molokoedov AS; Ovchinnikov MV; Bespalova ZhD
Bioorg Khim; 1995 Sep; 21(9):675-83. PubMed ID: 8588812
[TBL] [Abstract][Full Text] [Related]
16. Isolation of RP 71955, a new anti-HIV-1 peptide secondary metabolite.
Helynck G; Dubertret C; Mayaux JF; Leboul J
J Antibiot (Tokyo); 1993 Nov; 46(11):1756-7. PubMed ID: 8270499
[No Abstract] [Full Text] [Related]
17. A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition.
Wild C; Oas T; McDanal C; Bolognesi D; Matthews T
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10537-41. PubMed ID: 1438243
[TBL] [Abstract][Full Text] [Related]
18. Solution structure of human calcitonin gene-related peptide by 1H NMR and distance geometry with restrained molecular dynamics.
Breeze AL; Harvey TS; Bazzo R; Campbell ID
Biochemistry; 1991 Jan; 30(2):575-82. PubMed ID: 1988044
[TBL] [Abstract][Full Text] [Related]
19. Two partially overlapping antiviral peptides from the external portion of HIV type 1 glycoprotein 41, adjoining the transmembrane region, affect the glycoprotein 41 fusion domain.
Neurath AR; Lin K; Strick N; Jiang S
AIDS Res Hum Retroviruses; 1995 Feb; 11(2):189-90. PubMed ID: 7742033
[No Abstract] [Full Text] [Related]
20. Structure and dynamics of micelle-associated human immunodeficiency virus gp41 fusion domain.
Jaroniec CP; Kaufman JD; Stahl SJ; Viard M; Blumenthal R; Wingfield PT; Bax A
Biochemistry; 2005 Dec; 44(49):16167-80. PubMed ID: 16331977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
